IL6 and infection: Severity-of-illness indices (SAPS-II and MCCI) and inflammation-based biomarkers (NLR, PLR, CRP, and IL-6) were closely linked to both the timing of infection onset and in-hospital mortality, highlighting their potential value for early risk stratification in critically ill patients.